Hot Products
| Catalog No. | Information |
| CFN90998 | 8-Hydroxy-3,5,6,7,3',4'-hexamethoxyflavone 8-Hydroxy-3,5,6,7,3',4'-hexamethoxyflavone may have antifungal activity against phytopathogenic and human pathogenic fungi. |
| CFN90591 | 8-Hydroxybergapten 8-Hydroxybergapten may have anti-wrinkle activity. |
| CFN92432 | 8-Hydroxypinoresinol 8-Hydroxypinoresinol has antioxidant activity,it and phillygenin significantly reduce the cell injury by 3-morpholinosydnonimine (SIN-1), a ONOO− generator, may be useful for the therapeutic or preventive applications in treating ONOO−-related diseases. |
| CFN95083 | 8-Hydroxypinoresinol diglucoside Reference standards. |
| CFN95356 | 8-Hydroxypinoresinol-4'-O-beta-D-glucopyranoside |
| CFN92382 | 8-Methoxykaempferol Standard reference |
| CFN97181 | 8-O-Acetylharpagide 8-O-Acetylharpagide has anti-inflammatory, vasoconstrictor, antibacteria and antiviral activities, it also has a biological activity on isolated smooth muscle preparations from guinea pig. 8-O-Acetylharpagide presents the obvious inhibition on Epstein-Barr virus(EBV) infection, it not only apparently inhibits EBV-VCA,but also alleviates the hyperfunction and effusion of capillary permeability at the early inflammation. |
| CFN98966 | 8-O-Acetylshanzhiside methyl ester 8-O-Acetylshanzhiside methyl ester(ND01) has potential against cerebral ischemic injury and experimental myocardial ischemia injury, it can increase angiogenesis and improve functional recovery after stroke. ND01 protects diabetic brain against I/R injury by alleviating diabetic cerebral I/R injury and attenuating blood–brain barrier (BBB) breakdown, and its protective effects may involve HMGB-1 and NF-κB signalling pathway. |
| CFN97500 | 8-O-Demethyl-7-O-methyl-3,9-dihydropunctatin Reference standards. |
| CFN92157 | 8-Oxyberberine Reference standards. |
